GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XORTX Therapeutics Inc (NAS:XRTX) » Definitions » 5-Year Yield-on-Cost %

XORTX Therapeutics (XORTX Therapeutics) 5-Year Yield-on-Cost % : 0.00 (As of May. 02, 2024)


View and export this data going back to 2018. Start your Free Trial

What is XORTX Therapeutics 5-Year Yield-on-Cost %?

XORTX Therapeutics's yield on cost for the quarter that ended in Sep. 2023 was 0.00.


The historical rank and industry rank for XORTX Therapeutics's 5-Year Yield-on-Cost % or its related term are showing as below:



XRTX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.855
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of XORTX Therapeutics's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, XORTX Therapeutics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XORTX Therapeutics's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XORTX Therapeutics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where XORTX Therapeutics's 5-Year Yield-on-Cost % falls into.



XORTX Therapeutics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of XORTX Therapeutics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

XORTX Therapeutics  (NAS:XRTX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


XORTX Therapeutics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of XORTX Therapeutics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


XORTX Therapeutics (XORTX Therapeutics) Business Description

Traded in Other Exchanges
Address
3710 - 33rd Street NW, Calgary, AB, CAN, T2L 2M1
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.